|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 12 of 22 found articles
| Title: |
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial |
| Author: |
Fisher, Benjamin A Veenith, Tonny Slade, Daniel Gaskell, Charlotte Rowland, Matthew Whitehouse, Tony Scriven, James Parekh, Dhruv Balasubramaniam, Madhu S Cooke, Graham Morley, Nick Gabriel, Zoe Wise, Matthew P Porter, Joanna McShane, Helen Ho, Ling-Pei Newsome, Philip N Rowe, Anna Sharpe, Rowena Thickett, David R Bion, Julian Gates, Simon Richards, Duncan Kearns, Pamela |
| Appeared in: |
Lancet respiratory medicine |
| Paging: | Volume 10 () nr. 3 pages 255-266 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 12 of 22 found articles
| << previous | next >> |